Yosuke Sugiyama
Papers
2
Total Citations
6
H-Index
2
About
Yosuke Sugiyama is a urologic oncology researcher whose work centers on improving outcomes for prostate cancer patients through both novel therapeutic strategies and refined surgical techniques. His most impactful contribution explores the chemopreventive potential of luteolin, a natural flavonoid, for men with prostate cancer under active surveillance. In his highly cited 2025 study, Sugiyama provided preliminary evidence on the safety and clinical efficacy of luteolin, addressing the critical need for non-toxic interventions that may delay or prevent disease progression—a finding with significant implications for managing the re-emergence of cancer after androgen deprivation therapy. Complementing this work, Sugiyama has also advanced the understanding of post-surgical quality of life. His 2023 study identified the postoperative bladder neck to pubic symphysis ratio as a novel predictive factor for de novo overactive bladder following robot-assisted radical prostatectomy, including the Retzius-sparing approach. This research offers clinicians a practical, imaging-based tool to anticipate and manage a common and distressing complication. With a growing citation footprint, Sugiyama is establishing himself as a researcher who bridges natural product pharmacology and surgical precision to address the full spectrum of prostate cancer care.
Research Focus
Key Achievements
Top Papers
- 1
- 2